The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Next-Generation Oncology Devices And Solutions Market Evolve From 2026 To 2030?
The market for next-generation oncology devices and solutions has demonstrated substantial growth in its size over recent years. This market is projected to expand from $16.41 billion in 2025 to $19.46 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.6%. The historical growth of this market can be attributed to a rise in global cancer incidence, the broadening of molecular diagnostic capabilities, the emergence of advanced oncology testing instruments, the development of hospital-based cancer care programs, and an increasing uptake of targeted therapies.
The next-generation oncology devices and solutions market is anticipated to experience significant expansion in the coming years, with its size projected to reach $38.19 billion in 2030, at a compound annual growth rate (CAGR) of 18.4%. This anticipated growth over the forecast period is primarily fueled by factors such as the escalating demand for personalized cancer treatments, increased investments in genomic diagnostics, the broadening of early screening initiatives, the growing incorporation of artificial intelligence into oncology workflows, and advancements in biomarker-based cancer management. Furthermore, prominent trends expected during this period include the wider adoption of precision oncology platforms, a rise in the use of NGS-based cancer diagnostics, the expanding integration of digital pathology solutions, the continued spread of personalized cancer treatment approaches, and an intensified focus on technologies for early detection.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24336&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Next-Generation Oncology Devices And Solutions Market?
The growing incidence of cancer is anticipated to fuel the expansion of the next-generation oncology devices and solutions market in the future. Cancer is a condition characterized by the uncontrolled multiplication of abnormal cells, which can spread throughout the body and disrupt normal bodily functions. The heightened occurrence of cancer is primarily attributable to an aging populace, given that the likelihood of developing cancer escalates with advancing age. To address this growing prevalence, next-generation oncology devices and solutions offer significant assistance through facilitating earlier detection, more accurate diagnoses, and tailored treatment approaches. As an illustration, the American Cancer Society, a US-based nonprofit organization, projected in January 2024 that cancer would be responsible for over 611,000 fatalities in the United States, which translates to more than 1,600 daily cancer-related deaths. Consequently, the escalating incidence of cancer is poised to stimulate the expansion of the next-generation oncology devices and solutions market.
Which Segment Areas Are Covered In The Next-Generation Oncology Devices And Solutions Market Analysis?
The next-generation oncology devices and solutions market covered in this report is segmented –
1) By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), DNA Microarrays, Multiplexing, Other Technologies
3) By Application: Screening And Early Detection, Prognostics And Monitoring, Therapy Selection, Recurrence Monitoring, Other Applications
4) By End Use: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Uses
Subsegments:
1) By Breast Cancer: Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer
2) By Cervical Cancer: Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
3) By Colorectal Cancer: Colon Cancer, Rectal Cancer, Metastatic Colorectal Cancer
4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma
What Key Developments And Trends Are Impacting The Next-Generation Oncology Devices And Solutions Market?
Leading firms within the next-generation oncology devices and solutions market are prioritizing technological innovations, specifically next-generation sequencing (NGS) target enrichment solutions, to enhance the discovery of uncommon genetic variations, boost the precision of sequencing, and expedite decisions regarding cancer diagnosis and treatment. These NGS target enrichment solutions involve methodologies that selectively isolate and enrich particular segments of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) for subsequent sequencing, facilitating a more precise and efficient examination of genetic variants linked to conditions like cancer. An example occurred in April 2025, when Integrated DNA Technologies (IDT), a biotechnology company based in the US, introduced the xGen Hybridization and Wash v3 Kit. This novel hybridization capture solution aims to speed up cancer research by optimizing next-generation sequencing (NGS) workflows. This innovative kit notably cuts the hybridization time down to just one hour, allowing researchers to finish sample preparation and move to sequencing within a single working day. With the elimination of heated buffers and a 20% reduction in hands-on time, this solution is highly compatible with automation and ideal for high-throughput applications.
Which Global Companies Are Actively Competing In The Next-Generation Oncology Devices And Solutions Market?
Major companies operating in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., Lucida Medical Ltd.
Read the full next-generation oncology devices and solutions market report here:
What Are The Leading Geographic Regions In The Next-Generation Oncology Devices And Solutions Market?
North America was the largest region in the next-generation oncology devices and solutions market in 2025. The regions covered in the next-generation oncology devices and solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Next-Generation Oncology Devices And Solutions Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24336&type=smp
Browse Through More Reports Similar to the Global Next-Generation Oncology Devices And Solutions Market 2026, By The Business Research Company
Interventional Oncology Devices Market Report 2026
Oncology Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market
Oncology Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model